Post

Sight Sciences’ TearCare leads to long term improvement in dry eye disease

Sight Sciences revealed additional long-term data supporting its TearCare device for the treatment of dry eye disease, indicating it could …

Clinical trial landscape for Sub-Saharan Africa

According to GlobalData’s Clinical Trials Database, there has been an increase in clinical trial initiation in the Sub-Saharan region over …

Interim results of IGNAZ trial sheds positive light on felzartamab for IgAN

At this year’s European Renal Association Congress, positive interim results were presented from Human Immunology Bioscience’s Phase II IGNAZ clinical …

Insights on May: US Osteoporosis Awareness and Prevention Month

In May 2024, the US Bone Health and Osteoporosis Foundation (BHOF) celebrates Osteoporosis Awareness and Prevention Month, in which bone …

Vitestro’s robotic blood drawing device meets trial endpoints

Netherland-based Vitestro has announced positive results from a  trial evaluating the safety and efficacy of its autonomous blood-drawing device. The results …